Status:
COMPLETED
Pulsed Radiofrequency of Lateral Femoral Cutaneous Nerve
Lead Sponsor:
Mersin Training and Research Hospital
Conditions:
Meralgia Paresthetica
Eligibility:
All Genders
18-75 years
Brief Summary
In the current retrospective cohort study, conducted by both pain specialists and neurophysiologists, the primary outcome was to search for the effect of obesity on the efficacy of PRF of LFCN in refr...
Detailed Description
In the current retrospective cohort study, conducted by both pain specialists and neurophysiologists, the primary outcome was to search for the effect of obesity on the efficacy of PRF of LFCN in refr...
Eligibility Criteria
Inclusion
- older than 18 years treated with PRF neuromodulation of LFCN for MP
- followed up at least 6 months in the pain clinic of the tertiary hospital between January 2020 and August 2023.
Exclusion
- inadequate follow-up or missing documentation
- If a new analgesic drug was prescribed during the follow-up period that could affect the evaluation of outcomes, the patients were also excluded.
- Patients who missed appointments, or were unable to communicate with; were not included in the study.
- Patients with secondary entrapment neuropathy (e.g., diabetes, inflammatory arthritis, hypothyroidism), malignancy, pregnancy, skin infection in the inguinal region or dermatitis, lumbar radiculopathy, polyneuropathy, and cardiac pacemakers were excluded.
- In the SSEP analysis, when the latency of LFCN was not evaluated in both sides, these patients were not also included in the study.
Key Trial Info
Start Date :
November 21 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 6 2023
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06187883
Start Date
November 21 2023
End Date
December 6 2023
Last Update
April 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Suna Aşkın Turan
Mersin, Turkey (Türkiye)